Melanoma Institute Australia / Royal Prince Alfred Hospital
Welcome,         Profile    Billing    Logout  
 8 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hong, Angela
FaR-RMS, NCT04625907 / 2018-000515-24: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Recruiting
1/2
1672
Europe, RoW
Irinotecan, Actinomycin D, Dactinomycin, Doxorubicin, Ifosfamide, Vincristine, Vinorelbine, Cyclophosphamide, Temozolomide, radiotherapy, Regorafenib
University of Birmingham
Rhabdomyosarcoma
06/30
06/30
EPIC-Skin, NCT05135052: Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.

Recruiting
N/A
210
RoW
Rhenium-SCT
OncoBeta Therapeutics
Non-melanoma Skin Cancer
07/23
05/24
Gonzalez, Maria Jesus
ASPIRE, NCT04118088: A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula

Active, not recruiting
4
50
Europe, RoW
Darvadstrocel, Alofisel, Cx601
Takeda, Takeda Development Center Americas, Inc.
Crohn's Disease, Complex Perianal Fistula
03/26
03/26
NCT05357989: A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Completed
3
523
Europe, US
buntanetap/posiphen, Posiphen Tartrate, ANVS401, Placebo
Annovis Bio Inc., TFS Trial Form Support
Parkinson's Disease, Idiopathic
12/23
12/23
VITACTOH, NCT05754242: Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation

Recruiting
2
70
Europe
Ascorbic acid, Vitamin C, 0.9% Saline solution, Saline
Hospital Universitario Ramon y Cajal
Liver Transplantation, Postreperfusion Syndrome, Ascorbic Acid
06/23
07/23
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

Active, not recruiting
2
797
Canada, US, RoW
ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline
AEON Biopharma, Inc., PPD
Migraine
06/24
09/24
NCT03340129: Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Recruiting
2
218
Europe, RoW
Ipilimumab, Yervoy, Nivolumab, Opdivo, Stereotactic Radiotherapy, Salvage therapy
Melanoma Institute Australia, Bristol-Myers Squibb
Melanoma Stage Iv
08/24
08/25
ADEPPT, NCT05673187 / 2022-002736-31: Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status

Recruiting
2
68
Europe
Adagrasib
ETOP IBCSG Partners Foundation, Mirati Therapeutics Inc.
NSCLC Stage IV, KRAS P.G12C
10/25
03/26
STX-001-01, NCT06249048: Study of IT STX-001 in Patients With Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Recruiting
1/2
108
US, RoW
STX-001, Keytruda®, Pembrolizumab
Strand Therapeutics Inc.
Advanced Solid Tumor
05/27
11/28
NCT04232696: Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)

Active, not recruiting
N/A
242
Europe, US
Neuspera Implantable Sacral Nerve Stimulation System
Neuspera Medical, Inc.
Urinary Urgency Incontinence
07/24
12/26
FP COVID-19, NCT05616663: Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

Recruiting
N/A
639
Europe
University Hospital, Strasbourg, France
COVID-19
12/23
12/23
NCT02297724: MRI Assessment of Placental Health

Recruiting
N/A
80
Europe, US
Oxygen
Boston Children's Hospital, Massachusetts General Hospital, Massachusetts Institute of Technology, National Institute for Biomedical Imaging and Bioengineering (NIBIB), Madrid-MIT M+Visión Consortium
Intrauterine Growth Restriction
09/25
09/26
SeroPrevHUS, NCT05652582: Seroprevalence of Covid-19 in the Staff of the University Hospitals of Strasbourg

Completed
N/A
5694
Europe
University Hospital, Strasbourg, France
COVID-19
04/22
06/22

Download Options